| | |
Per Depositary
Share |
| |
Total
|
| ||||||
Initial Public Offering Price(1)
|
| | | | % | | | | | $ | | | |
Underwriting Discount and Commission(2)
|
| | | | % | | | | | $ | | | |
Proceeds, before expenses, to AIG(3)
|
| | | | % | | | | | $ | | | |
| BofA Merrill Lynch | | |
Morgan Stanley
|
| |
Wells Fargo Securities
|
|
| J.P. Morgan | | |
RBC Capital Markets
|
|
| | |
Page
|
| |||
| | | | S-iii | | | |
| | | | S-iv | | | |
| | | | S-vi | | | |
| | | | S-1 | | | |
| | | | S-6 | | | |
| | | | S-10 | | | |
| | | | S-11 | | | |
| | | | S-12 | | | |
| | | | S-20 | | | |
| | | | S-25 | | | |
| | | | S-30 | | | |
| | | | S-36 | | | |
| | | | S-36 | | |
| | |
Page
|
| |||
| | | | ii | | | |
| | | | ii | | | |
| | | | iv | | | |
| | | | 1 | | | |
| | | | 1 | | | |
| | | | 2 | | | |
| | | | 14 | | | |
| | | | 18 | | | |
| | | | 20 | | | |
| | | | 23 | | | |
| | | | 24 | | | |
| | | | 26 | | | |
| | | | 35 | | | |
| | | | 38 | | | |
| | | | 44 | | | |
| | | | 63 | | | |
| | | | 65 | | | |
| | | | 65 | | | |
| | | | 65 | | |
| | |
At December 31, 2018
|
| |||||||||
| | |
Actual
|
| |
As Adjusted for
the Issuance of the Depositary Shares(a) |
| ||||||
| | |
(In millions)
|
| |||||||||
Cash
|
| | | $ | 2,873 | | | | | $ | | | |
Debt: | | | | | | | | | | | | | |
Debt issued or guaranteed by AIG:
|
| | | | | | | | | | | | |
General Borrowings
|
| | | | | | | | | | | | |
Notes and bonds payable
|
| | | | 21,494 | | | | | | 21,494 | | |
AIG Japan Holdings Kabushiki Kaisha
|
| | | | 331 | | | | | | 331 | | |
Junior subordinated debt
|
| | | | 1,909 | | | | | | 1,909 | | |
Borrowings supported by assets:
|
| | | | | | | | | | | | |
Series AIGFP matched notes and bonds payable
|
| | | | 21 | | | | | | 21 | | |
Other
|
| | | | 2,213 | | | | | | 2,213 | | |
Debt not guaranteed by AIG
|
| | | | 8,572 | | | | | | 8,572 | | |
Total debt
|
| | | | 34,540 | | | | | | | | |
Shareholders’ equity: | | | | | | | | | | | | | |
Preferred stock, $5.00 par value; 100,000,000 shares authorized; shares of Series A Preferred Stock, as adjusted
|
| | | | 0 | | | | | | | | |
Common stock, $2.50 par value; 5,000,000,000 shares authorized; shares issued: 1,906,671,492
|
| | | | 4,766 | | | | | | 4,766 | | |
Treasury stock, at cost; 1,040,062,063 shares of common stock
|
| | | | (49,144) | | | | | | (49,144) | | |
Additional paid-in capital
|
| | | | 81,268 | | | | | | 81,268 | | |
Retained earnings
|
| | | | 20,844 | | | | | | 20,844 | | |
Accumulated other comprehensive income
|
| | | | (1,413) | | | | | | (1,413) | | |
Total AIG shareholders’ equity
|
| | | | 56,361 | | | | | | | | |
Non-redeemable noncontrolling interests
|
| | | | 948 | | | | | | 948 | | |
Total equity
|
| | | | 57,309 | | | | | | | | |
Total capitalization
|
| | | $ | 91,849 | | | | | $ | | | |
|
Underwriters
|
| |
Number of
Depositary Shares |
|
Merrill Lynch, Pierce, Fenner & Smith
Incorporated |
| |
|
|
Morgan Stanley & Co. LLC
|
| | | |
Wells Fargo Securities, LLC
|
| | | |
J.P. Morgan Securities LLC
|
| | | |
RBC Capital Markets, LLC
|
| | | |
Total
|
| | | |
|
|
Per Depositary Share(1)
|
| | | | % | | |
| Total(2) | | | | $ | | |
| | | | | ii | | | |
| | | | | ii | | | |
| | | | | iv | | | |
| | | | | 1 | | | |
| | | | | 1 | | | |
| | | | | 2 | | | |
| | | | | 14 | | | |
| | | | | 18 | | | |
| | | | | 20 | | | |
| | | | | 23 | | | |
| | | | | 24 | | | |
| | | | | 26 | | | |
| | | | | 35 | | | |
| | | | | 38 | | | |
| | | | | 44 | | | |
| | | | | 63 | | | |
| | | | | 65 | | | |
| | | | | 65 | | | |
| | | | | 65 | | |
| Issuer | | | American International Group, Inc. | |
| Warrant Shares to be issued, assuming full exercise of all Warrants | | | As of February 15, 2018, full exercise of the warrants would result in issuance of up to 58,424,708 shares of common stock, subject to adjustment. | |
|
Net proceeds, assuming full exercise of all Warrants
|
| | Approximately $2.571 billion (at the current exercise price of $44.0005 per share). | |
| NYSE Listing for our common stock | | | “AIG” | |
| NYSE Listing for our Warrants | | | “AIG WS” | |
| Aggregate number of Warrants (outstanding as of February 15, 2018) | | | 57,111,151.829 | |
| Exercisability | | | Each Warrant is exercisable for 1.023 Warrant Shares, subject to adjustment. | |
| Exercise Price | | | $44.0005 per share, subject to adjustment. The Warrants require the payment of cash consideration. Further adjustments are likely to occur as described under “Anti-dilution Adjustments” below. | |
| Exercise Period | | | The Warrants are generally exercisable at any time until 5:00 p.m., New York time, on January 19, 2021 (or, if that date is not a business day, the next business day), subject to the terms and conditions set forth in the Warrant Agreement (as defined below). In particular, the Warrants will be exercisable only if a registration statement relating to the Warrant Shares issuable upon exercise is effective and current. | |
| EP0 | | | = | | | the exercise price in effect at the close of business on the record date | |
| EP1 | | | = | | | the exercise price in effect immediately after the record date | |
| OS0 | | | = | | | the number of shares of common stock outstanding at the close of business on the record date prior to giving effect to such event | |
| OS1 | | | = | | | the number of shares of common stock that would be outstanding immediately after, and solely as a result of, such event | |
| EP0 | | | = | | | the exercise price in effect at the close of business on the record date | |
| EP1 | | | = | | | the exercise price in effect immediately after the record date | |
| OS0 | | | = | | | the number of shares of common stock outstanding at the close of business on the record date prior to giving effect to such event | |
| X | | | = | | | the total number of shares of common stock issuable pursuant to such rights, options or warrants | |
| Y | | | = | | | the aggregate price payable to exercise such rights divided by the average of the VWAP (as defined below) per share of the common stock over each of the 10 consecutive trading days prior to the Business Day immediately preceding the announcement of the issuance of such rights, options or warrants | |
| EP0 | | | = | | | the exercise price in effect at the close of business on the record date | |
| EP1 | | | = | | | the exercise price in effect immediately after the record date | |
| SP0 | | | = | | | the Current Market Price as of the record date | |
| FMV | | | = | | | the Fair Market Value (as defined below), on the record date, of the shares of capital stock of AIG, rights to acquire capital stock, evidences of indebtedness or assets so distributed, expressed as an amount per share of common stock | |
| EP0 | | | = | | | the exercise price in effect at the close of business on the record date | |
| EP1 | | | = | | | the exercise price in effect immediately after the record date | |
| FMV0 | | | = | | | the average of the VWAP (as defined below) of the capital stock or similar equity interests distributed to holders of common stock applicable to one share of common stock over each of the 10 consecutive trading days commencing on and including the third trading day after the date on which “ex-distribution trading” commences for such dividend or distribution with respect to common stock on the NYSE or such other national or regional exchange or market that is at that time the principal market for the common stock | |
| MP0 | | | = | | | the average of the VWAP per share of the common stock over each of the 10 consecutive trading days commencing on and including the third trading day after the date on which “ex-distribution trading” commences for such dividend or distribution with respect to common stock on the NYSE or such other national or regional exchange or market that is at that time the principal market for the common stock | |
| SR0 | | | = | | | the exercise price in effect at the close of business on the record date | |
| SR1 | | | = | | | the exercise price in effect immediately after the record date | |
| SP0 | | | = | | | the Current Market Price as of the record date | |
| C | | | = | | | the excess of the amount in cash per share of common stock that AIG distributes to holders over the Dividend Threshold Amount | |
| EP0 | | | = | | | the exercise price in effect at the close of business on the offer expiration date | |
| EP1 | | | = | | | the exercise price in effect immediately after the offer expiration date | |
| FMV | | | = | | | the Fair Market Value, on the offer expiration date, of the aggregate value of all cash and any other consideration paid or payable for shares validly tendered and not withdrawn as of the offer expiration date (the “Purchased Shares”) | |
| OS1 | | | = | | | the number of shares of common stock outstanding at the last time tenders may be made pursuant to such tender offer (the “Expiration Time”) less any Purchased Shares | |
| OS0 | | | = | | | the number of shares of common stock outstanding at the Expiration Time, including any Purchased Shares | |
| SP1 | | | = | | | the average of the VWAP per share of the common stock over each of the 10 consecutive trading days commencing with the trading day immediately after the Expiration Time | |
| BofA Merrill Lynch | | |
Morgan Stanley
|
| |
Wells Fargo Securities
|
|
| J.P. Morgan | | |
RBC Capital Markets
|
|